SLNO Long Call Strategy
SLNO (Soleno Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
SLNO (Soleno Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.76B, a trailing P/E of 28.72, a beta of -2.22 versus the broader market, a 52-week range of 29.43-90.32, average daily share volume of 3.5M, a public-listing history dating back to 2014, approximately 115 full-time employees. These structural characteristics shape how SLNO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -2.22 indicates SLNO has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on SLNO?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current SLNO snapshot
As of May 15, 2026, spot at $53.00, ATM IV 14.30%, IV rank 8.81%, expected move 4.10%. The long call on SLNO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on SLNO specifically: SLNO IV at 14.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a SLNO long call, with a market-implied 1-standard-deviation move of approximately 4.10% (roughly $2.17 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SLNO expiries trade a higher absolute premium for lower per-day decay. Position sizing on SLNO should anchor to the underlying notional of $53.00 per share and to the trader's directional view on SLNO stock.
SLNO long call setup
The SLNO long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SLNO near $53.00, the first option leg uses a $55.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SLNO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SLNO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $55.00 | $0.30 |
SLNO long call risk and reward
- Net Premium / Debit
- -$30.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$30.00
- Breakeven(s)
- $55.27
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
SLNO long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on SLNO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$30.00 |
| $11.73 | -77.9% | -$30.00 |
| $23.44 | -55.8% | -$30.00 |
| $35.16 | -33.7% | -$30.00 |
| $46.88 | -11.5% | -$30.00 |
| $58.60 | +10.6% | +$329.74 |
| $70.31 | +32.7% | +$1,501.49 |
| $82.03 | +54.8% | +$2,673.24 |
| $93.75 | +76.9% | +$3,844.99 |
| $105.47 | +99.0% | +$5,016.74 |
When traders use long call on SLNO
Long calls on SLNO express a bullish thesis with defined risk; traders use them ahead of SLNO catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
SLNO thesis for this long call
The market-implied 1-standard-deviation range for SLNO extends from approximately $50.83 on the downside to $55.17 on the upside. A SLNO long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current SLNO IV rank near 8.81% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SLNO at 14.30%. As a Healthcare name, SLNO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SLNO-specific events.
SLNO long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SLNO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SLNO alongside the broader basket even when SLNO-specific fundamentals are unchanged. Long-premium structures like a long call on SLNO are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current SLNO chain quotes before placing a trade.
Frequently asked questions
- What is a long call on SLNO?
- A long call on SLNO is the long call strategy applied to SLNO (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With SLNO stock trading near $53.00, the strikes shown on this page are snapped to the nearest listed SLNO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are SLNO long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the SLNO long call priced from the end-of-day chain at a 30-day expiry (ATM IV 14.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$30.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SLNO long call?
- The breakeven for the SLNO long call priced on this page is roughly $55.27 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SLNO market-implied 1-standard-deviation expected move is approximately 4.10%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on SLNO?
- Long calls on SLNO express a bullish thesis with defined risk; traders use them ahead of SLNO catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current SLNO implied volatility affect this long call?
- SLNO ATM IV is at 14.30% with IV rank near 8.81%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.